Alyeska Investment Group
IMGN

Alyeska Investment Group’s Immunogen Inc IMGN Stock Holding History

Alyeska Investment Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-150,000
Closed -$2.38M – 696
2023
Q3 		$2.38M Hold
150,000
– – 0.02% 378
2023
Q2 		$2.83M Buy
+150,000
New +$1.77M 0.02% 385
2022
Q1 		– Sell
-336,436
Closed -$2.5M – 692
2021
Q4 		$2.5M Buy
+336,436
New +$2.09M 0.03% 405
2018
Q4 		– Sell
-100,000
Closed -$947K – 485
2018
Q3 		$947K Buy
+100,000
New +$961K 0.01% 352

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Alyeska Investment Group's IMGN Position: Q4 2023 in Review

Alyeska Investment Group sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 150,000 shares — an estimated $2.38M sold.

Alyeska Investment Group first reported a position in IMGN in Q3 2018 and held it in 4 quarters. The position peaked at $2.83M in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Alyeska Investment Group reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 150,000 Immunogen Inc shares in Q4 2023, an estimated $2.38M.
  • Alyeska Investment Group first reported a position in Immunogen Inc in Q3 2018 and held it in 4 quarters.
  • Alyeska Investment Group's Immunogen Inc position peaked at $2.83M in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.